Recent News

By Category: Research

Higher-Level TB Research to Begin at NEIDL

(BostonUniversity) BU’s National Emerging Infectious Diseases Laboratories will begin doing tuberculosis research at a higher biosafety level in the coming months, following approval of the work by the Boston Public Health Commission. The research will be transferred from another lab on the Medical Campus. TB researchers Igor Kramnik, a School of Medicine professor of medicine Read More »

October 31, 2013
| Filed under North America, Biosafety, and Research
Share

New molecular target for malaria control identified

(Eurekalert) A new study led by Harvard School of Public Health (HSPH) and University of Perugia (UNIPG) researchers has shown that egg development in the mosquito species primarily responsible for spreading malaria depends on a switch in the female that is turned on by a male hormone delivered during sex. Blocking the activation of this Read More »

October 30, 2013
| Filed under Europe, North America, and Research
Share

HHS Boosts Global Ability to Respond to Pandemics

(GlobalBiodefense) To build a sustainable capacity to manufacture influenza vaccine in developing countries and help reduce the global threat of influenza pandemics, the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) recently announced grants totaling $15 million to two international organizations and two U.S. universities.

October 29, 2013
| Filed under North America, Countermeasures, Policy & Initiatives, Public Health, and Research
Share

Policing the New Scientific Frontier of Synthetic Biology

(ForeignAffairs) Ongoing research and discoveries in the life sciences — the latest and most promising involving synthetic biology — have led to extraordinary advances that will benefit society. But criminals and terrorists could manipulate such advances to disrupt public safety and national security. Since its founding in 1923, Interpol has learned that the most effective Read More »

October 28, 2013
| Filed under Africa, Asia/Pacific, Europe, Middle East, North America, South America, South Asia, Biosafety, Bioterrorism, International, Policy & Initiatives, and Research
Share

Deadly gaps persist in new drug development for neglected diseases

(EurekaAlert) In a study published today in the open-access journal The Lancet Global Health, the Drugs for Neglected Diseases initiative (DNDi) and other researchers report a persistent deficiency in truly new therapeutics for neglected diseases, despite nominal progress and an acceleration in research and development (R&D) efforts. This continued ‘fatal imbalance’ in medical R&D points Read More »